Covid Nasal Vaccine In India: Know How Effective Is The New Nasal Vaccine & Who Can Take It, Watch Video

BBV154 may produce local antibodies in the upper respiratory tract. These may provide the potential to reduce infection and transmission, Two separate and simultaneous clinical trials were conducted, To evaluate BBV154 as a primary dose (2-dose) booster dose for subjects who have previously received 2 doses of the vaccine.

Nasal Vaccine India: BBV154 may produce local antibodies in the upper respiratory tract. These may provide the potential to reduce infection and transmission, Two separate and simultaneous clinical trials were conducted, To evaluate BBV154 as a primary dose (2-dose) booster dose for subjects who have previously received 2 doses of the vaccine. Watch Video.